Tiam1 mutations in human renal-cell carcinomas
β Scribed by Rainer Engers; Thomas P. Zwaka; Lutz Gohr; Achim Weber; Claus-Dieter Gerharz; Helmut E. Gabbert
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- French
- Weight
- 199 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cyclin-D1 over-expression represents one of several common alterations in the G 1 -S transition associated with malignancies. Conclusive evidences indicate that cyclin D1 is a proto-oncogene and the gene is amplified or rearranged in different tumour types. Since very little is known about aberratio
## BACKGROUND. Telomerase activity has been shown to be increased in numerous tumors and cell lines, although to the authors' knowledge there has been no previous assessment of telomerase activity in renal cell carcinoma (RCC). To examine whether telomerase activity could be used as a biochemical p
Loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 is a characteristic finding in chromophobe renal-cell carcinoma (ChRCC). Previously, cytogenetic and molecular genetic techniques were used in demonstrating the chromosomal monosomies in ChRCCs. We performed interphase fluorescent in situ hybridization
I n developing this proposal, the authors applied these principles: 1. The classification must be based on morphology yet be in line with the genetic facts as they are presently understood, and in line with the evolution of the neoplasms. 2. The terms should be simple, unambiguous, and reflect a sa
Xenografts from four metastatic renal cell carcinomas (RCCs) were established in immunodeficient mice. All tumors exhibited cytogenetic features specific for the papillary subtype, namely, partial or total polysomy of chromosomes 7 and 17 and integrity of 3p. Cytogenetic analysis of the initial and